Short sighted pharma undermining its own future, says Oxfam
November 30, 2007Sales and Marketing
Pharmaceutical companies are damaging their businesses by blocking access to drugs for millions of people in the developing world, according …
Wyeth kidney cancer drug approved in Europe
November 29, 2007Sales and Marketing
Wyeth's orphan cancer drug Torisel has been approved in Europe for difficult to treat cases of advanced renal cell carcinoma.It …
European approval for Merck’s cyanide antidote
November 29, 2007Sales and Marketing
European regulators have approved Merck Serono's cyanide poisoning cure Cyanokit for use in adults and children. Cyanide poisoning is primarily …
Latest news from Datamonitor
November 29, 2007Research and Development
Medivir to initiate Phase IIa study of hepatitis CMedivir has announced that a Phase IIa study for its investigational hepatitis …
Do regional marketing teams really work?
November 29, 2007Sales and Marketing Europe, marketing, regional marketing
In this feature, we tackle the subject of the regional marketing team and look at a number of issues, including …
The new prescriber: friend or foe?
November 22, 2007Sales and Marketing nursing, pharma, pharmacy, sales
Champix linked to depression and suicidal thoughts
November 22, 2007Sales and Marketing reg, safety
Pfizer has alerted US regulator the FDA to cases of depression and suicidal thoughts in patients taking its smoking cessation …
Pfizer buys immune system specialists Coley
November 22, 2007Research and Development
Pfizer is to acquire a company developing new drugs that fight diseases by altering the immune system. The company is …
NHS set for major underspend
November 22, 2007Efforts to save money in the NHS have proved so successful that the health service is set to underspend its …
Ethical dilemma for doctors must be confronted, says bowel cancer charity
November 22, 2007Many bowel cancer patients are not being informed of all treatment options because their doctors feel embarrassed about having a …
Latest news from Datamonitor
November 20, 2007Research and Development
Aeterna completes enrollment for Phase II trial of lung cancerAeterna Zentaris has completed patient recruitment for its European multi-center Phase …
Prexige pulled from UK market
November 20, 2007Sales and Marketing prexige
Novartis' Prexige has been taken off the market and UK doctors instructed to immediately stop prescribing it following several instances …
Private sector schemes axed
November 16, 2007NHS, private sector
Poor value for money and improvements in the NHS have forced a number of planned private sector schemes to be …
Rules on patient groups to change
November 16, 2007Medical Communications ethics
UK pharma companies have until next July to conform to new rules aimed at making their relations with patient groups …
New software aims to cut hospital admissions
November 16, 2007Doctors and clinicians will have access to a free new computer program that can help them reduce the number of …
J&J unveils new ‘comprehensive care’ strategy
November 16, 2007Sales and Marketing
Johnson & Johnson is to re-model its business operations into more customer-focused units, including a 'comprehensive care' arm that will …
GSK scales back US health warnings for Avandia
November 15, 2007Sales and Marketing
GlaxoSmithKline will update US labelling for its diabetes treatment Avandia to state there is no conclusive evidence linking it to …
Remicade loses out in ankylosing spondylitis
November 15, 2007Sales and Marketing TNF
NICE has rejected Schering-Plough's Remicade as a treatment for the debilitating form of spinal inflammation known as ankylosing spondylitis.The Institute …
Merck to pay $4.9 billion to end Vioxx claims
November 15, 2007Sales and Marketing Vioxx, safety
Merck looks set to pay $4.9 billion in a settlement for the thousands of people claiming injury after taking its …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
